| Literature DB >> 27771469 |
Nadia Ben Fredj1, Kaouthar Sakly2, Daria Bortolotti3, Mouna Aissi4, Mahbouba Frih-Ayed4, Antonella Rotola3, Elisabetta Caselli3, Franscesca Cura3, Nabil Sakly2, Mahjoub Aouni5, Dario Di Luca3, Roberta Rizzo3.
Abstract
We aimed to investigate two main polymorphisms in the 3' untranslated region (3'UTR) of the HLA-G gene [14bp insertion/deletion (INS/DEL) and +3142 C>G] and to assess their impact on the soluble HLA-G (sHLA-G) production in patients with multiple sclerosis (MS). This study included 60 patients with relasping-remitting (RR) MS and 112 healthy donors (HD). Mutations were identified by PCR and PCR-RFLP, and serum sHLA-G quantification was performed by ELISA. For the 14bp INS/DEL polymorphism, variants frequencies were similar in patients and controls, whereas a significant increased frequency of the +3142 G allele was found in MS patients compared to HD (63.4% vs 52.3%, p=0.04; OR=1.58, 95%CI=1.003-2.48). In addition, an association was found between MS susceptibility and the haplotypes regrouping both studied polymorphisms. Indeed, the 14bp DEL/+3142 G haplotype frequency was significantly increased in MS patients compared to HD (20.8% vs 12.5%, p=0.04, OR=1.84). On the other hand, no associations were detected between both polymorphisms and clinical parameters, except the lower age of disease onset (ADO) in patients with the +3142 C/C genotype. Moreover, our study doesn't show any significant variation of sHLA-G serum levels between patients and controls. Our findings showed that the +3142 C>G, but not the 14bp INS/DEL, polymorphism may constitute a genetic susceptibility factor to MS in the Tunisian population. However, no association was found between the two polymorphisms and sHLA-G serum levels. Copyright ÂEntities:
Keywords: Genetic polymorphism; HLA-G antigens; Haplotypes; Multiple sclerosis; Tunisia
Mesh:
Substances:
Year: 2016 PMID: 27771469 DOI: 10.1016/j.imlet.2016.10.006
Source DB: PubMed Journal: Immunol Lett ISSN: 0165-2478 Impact factor: 3.685